Peter E Zage Selected Research

Peter E Zage Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 07/2006
26	Neuroblastoma 01/2022 - 12/2008
3	Medulloblastoma 01/2021 - 10/2016
2	Carcinogenesis 01/2022 - 07/2009
2	Glioma (Gliomas) 01/2012 - 07/2006
1	Ewing Sarcoma (Sarcoma, Ewing) 12/2020
1	Rhabdomyosarcoma 12/2020
1	Infections 10/2020
1	Bacterial Infections (Bacterial Infection) 10/2020
1	Neutropenia 10/2020
1	Neural crest tumor 01/2017
1	Melanoma (Melanoma, Malignant) 07/2015
1	Precocious Puberty 01/2011
1	Retinoblastoma (Glioblastoma, Retinal) 03/2008

Drug/Important Bio-Agent (IBA)

9	Phosphotransferases (Kinase)IBA 12/2020 - 07/2009
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2013
5	Etoposide (VP 16)FDA LinkGeneric 07/2015 - 07/2006
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2020 - 07/2015
4	Isotretinoin (Accutane)FDA LinkGeneric 01/2020 - 05/2010
4	Pharmaceutical PreparationsIBA 01/2015 - 07/2006
3	Temozolomide (Temodar)FDA LinkGeneric 12/2021 - 07/2015
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2019 - 10/2014
3	ErbB Receptors (EGF Receptor)IBA 02/2013 - 05/2010
2	AntibodiesIBA 05/2020 - 07/2014
2	NifurtimoxIBA 10/2016 - 07/2015
2	Growth Factor ReceptorsIBA 03/2016 - 02/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2016 - 11/2015
2	UbiquitinIBA 01/2016 - 02/2013
2	Ligases (Synthetase)IBA 01/2016 - 02/2013
2	Topotecan (Hycamtin)FDA LinkGeneric 11/2015 - 03/2011
2	Adenosine Triphosphate (ATP)IBA 01/2015 - 02/2012
2	Tyrosine (L-Tyrosine)FDA Link 07/2010 - 05/2010
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Protein Tyrosine PhosphatasesIBA 01/2022
1	PlatinumIBA 12/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2020
1	AZD4547IBA 12/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2020
1	Monoclonal AntibodiesIBA 05/2020
1	Histidine (L-Histidine)FDA Link 05/2020
1	Histidine KinaseIBA 05/2020
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 01/2020
1	regorafenibIBA 01/2020
1	agerafenibIBA 10/2019
1	ponatinibIBA 12/2016
1	Tyrosine Kinase InhibitorsIBA 12/2016
1	Buthionine SulfoximineIBA 10/2016
1	Neurofibromin 1 (Neurofibromin)IBA 03/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2016
1	DNA (Deoxyribonucleic Acid)IBA 03/2016
1	binimetinibIBA 03/2016
1	cabozantinibIBA 11/2015
1	Cell Surface ReceptorsIBA 07/2015
1	Antineoplastic Agents (Antineoplastics)IBA 07/2015
1	sapanisertibIBA 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	EMD1214063IBA 10/2014
1	Topoisomerase InhibitorsIBA 07/2014
1	Liposomes (Liposome)IBA 07/2014
1	RNA (Ribonucleic Acid)IBA 05/2014
1	Cetuximab (Erbitux)FDA Link 02/2013
1	hepatocyte growth factor-regulated tyrosine kinase substrateIBA 02/2013
1	Notch ReceptorsIBA 05/2012
1	Decitabine FDA Link 05/2012
1	MTOR InhibitorsIBA 02/2012
1	Oxygen (Dioxygen)IBA 02/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2012
1	Sirolimus (Rapamycin)FDA Link 02/2012
1	dipinacoline glutamateIBA 01/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2011
1	trkB ReceptorIBA 03/2011
1	Messenger RNA (mRNA)IBA 03/2011
1	GonadotropinsIBA 01/2011
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2011
1	ChromatinIBA 10/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2010
1	Canertinib (CI 1033)IBA 07/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2010
1	vandetanib (ZD6474)IBA 05/2010
1	Nerve Growth Factors (Neurotrophins)IBA 07/2009
1	Retinaldehyde (Retinal)IBA 03/2008
1	Carboplatin (JM8)FDA LinkGeneric 03/2008

Therapy/Procedure

20	Therapeutics 01/2021 - 03/2008
6	Drug Therapy (Chemotherapy) 12/2021 - 03/2008
5	Aftercare (After-Treatment) 10/2016 - 07/2006
3	Immunotherapy 10/2018 - 07/2012
2	Induction Chemotherapy 10/2020 - 12/2008
1	Critical Care (Surgical Intensive Care) 10/2020
1	Treatment Delay 10/2020
1	Palliative Care (Palliative Therapy) 01/2012
1	Radiotherapy 01/2012
1	Oral Administration 07/2009
1	Stem Cell Transplantation 12/2008